Vitros Immunodiagnostic Products Ca 125 Ii Calibrators, Vitros Immunodiagnostic Products Ca 125 Ii Reagent Pack
Test, Epithelial Ovarian Tumor-Associated Antigen (Ca125). 510(k) K983875, from Ortho-Clinical Diagnostics, Inc. (Rochester, NY). Product code LTK, class 2.
As of Nov 20, 2026, K983875 is an FDA 510(k) held by Ortho-Clinical Diagnostics, Inc., substantially equivalent on May 14, 1999 after 193 days, with 1 recall tied to it in FDA's recall database.
- Review time: 193 days
- Recalls: 1
- Cited as a predicate by: 1 device
The Vitros® CA 125 II is an in vitro assay intended for the quantitative measurement of OC 125 defined antigen in the serum or plasma (EDTA or heparin). The Vitros CA 125 II assay is to be used as an aid in monitoring response to therapy for patients with epithelial ovarian cancer.
- Elecsys Ca 125 IiK972162 · Boehringer Mannheim Corp. · Mar 18, 1998
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
| Started | Recall | Status |
|---|---|---|
| Oct 9, 2013 | Z-0525-2014Ortho Clinical Diagnostics issued a Product Correction Notification for VITROS Immunodiagnostic Products CA 125 II Reagent Pack and Calibrators due to a positive shift in patient results. | Terminated |
- Access OV MonitorK240479 · Beckman Coulter, Inc. · May 10, 2024
- Immulite/Immulite 1000 Om-Ma, Immulite 2000 Om-MaK213510 · Siemens Healthcare Diagnostics Products, Ltd. · Sep 8, 2023
- VITROS Immuodiagnostic Products CA 125 II Reagent PackK221355 · Ortho Clinical Diagnostics · Dec 12, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Nov 2, 1998
- Review panel
- Immunology
- Regulation
- 21 CFR 866.6010
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files